Breast Cancer Clinical Trial
— ITACTsOfficial title:
Interest of Self-compression Technique on Tolerance of Mammography
| NCT number | NCT02866591 |
| Other study ID # | 2012-A00248-35 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | May 2013 |
| Est. completion date | December 2016 |
| Verified date | August 2018 |
| Source | Institut de Cancérologie de Lorraine |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Mammography is used for screening, diagnosis, therapeutic evaluation and monitoring of local
cancer breast.
It is sometimes poorly tolerated by some patients who complain of an uncomfortable
examination or pain.
Breast compression by the manipulator aims to reduce the thickness of the breast during
mammography; This act is an important factor of pain or discomfort felt by the patient. But,
it is also an image quality factor.
This study aimed to compare self-breast compression by the patient to the compression
standard technique carried out by the manipulator.
| Status | Completed |
| Enrollment | 550 |
| Est. completion date | December 2016 |
| Est. primary completion date | December 2016 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years to 75 Years |
| Eligibility |
Inclusion Criteria: - Adult patients = 18 years and = 75 years of age - ECOG performance <2 - Mammography planned as part of a breast cancer screening or a monitoring following treatment of a breast lesion - Ability to provide written informed consent - Patient's legal capacity to consent to study participation and to understand and comply with the requirements of the study. Exclusion Criteria: - Eastern Cooperative Oncology Group performance status = 2 - Treatment for benign lesion with surgery for less than 3 years - Treatment for cancer with surgery and / or radiotherapy for less than 3 years - Biopsy for less than 1 year - Breast prosthesis - Mastectomy - Assessment motivated by a clinical breast abnormality |
| Country | Name | City | State |
|---|---|---|---|
| France | Institut Bergonié | Bordeaux | |
| France | Centre François Baclesse | Caen | |
| France | Cabinet de radiologie | Nancy | |
| France | Polyclinique Majorelle | Nancy | |
| France | Institut Curie | Paris | |
| France | Institut de Cancérologie de Lorraine | Vandoeuvre-les-Nancy |
| Lead Sponsor | Collaborator |
|---|---|
| Institut de Cancérologie de Lorraine |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Comparison of two breast compression techniques (auto-compression versus standard procedure) in mammography | The comparison will be evaluated by the thickness (mm) of breast compressed | 1 day | |
| Secondary | Overall tolerance of mammography | The overall tolerance of mammography will be assessed by the patient after 4 shots. The pain felt by the patient will be assessed using a visual analog scale. | 1 day | |
| Secondary | Breast compression force | Value measured on compressive force console (Newtons) | 1 day | |
| Secondary | Thickness / compressing force ratio | 1 day | ||
| Secondary | Image quality | The image quality will be assessed by the radiologist with a quotation of motion blurring on a 4-point scale | 1 day | |
| Secondary | Overall assessment of the manipulator | The appreciation of the manipulator will be assessed using a 4-point scale | 1 day | |
| Secondary | Overall assessment of self-satisfaction of the patient at the end of the examination | The measurement of patient satisfaction will be evaluated using a self-administered Norwegian questionnaire (MammoGraphy Questionnaire) | 1 day |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |